BerandaRGEN • NASDAQ
add
Repligen Corp
$124,02
Setelah Jam Perdagangan Normal:(0,00%)0,00
$124,02
Tutup: 25 Jun, 16.40.46 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$123,35
Rentang hari
$121,62 - $126,61
Rentang tahun
$102,97 - $182,06
Kapitalisasi pasar
6,97Â M USD
Volume Rata-Rata
775,68Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 169,17Â jt | 10,44% |
Biaya operasional | 81,92Â jt | 13,50% |
Laba bersih | 5,83Â jt | 76,88% |
Margin laba bersih | 3,45 | 60,47% |
Penghasilan per saham | 0,39 | 39,29% |
EBITDA | 28,16Â jt | 27,61% |
Tarif pajak efektif | 26,60% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 697,23Â jt | -10,68% |
Total aset | 2,85Â M | -0,05% |
Total liabilitas | 866,66Â jt | -2,41% |
Total ekuitas | 1,99 M | — |
Saham yang beredar | 56,18 jt | — |
Harga terhadap nilai buku | 3,49 | — |
Tingkat pengembalian aset | 0,83% | — |
Tingkat pengembalian modal | 0,89% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 5,83Â jt | 76,88% |
Kas dari operasi | 15,00Â jt | -66,44% |
Kas dari investasi | -74,11Â jt | -786,25% |
Kas dari pembiayaan | -5,03Â jt | 43,95% |
Perubahan kas bersih | -60,13Â jt | -305,25% |
Arus kas bebas | 31,05Â jt | -34,31% |
Tentang
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden. Wikipedia
CEO
Didirikan
1981
Kantor pusat
Situs
Karyawan
1.778
